Rapid Micro Rejects Takeover Deal, Adopts Poison Pill To Thwart Investor
Rapid Micro Biosystems Inc (NASDAQ: RPID) has initiated a review of strategic alternatives and has retained Morgan Stanley & Co. LLC as…
Columbia Care Seed & Strain Pre-Rolls Hit New York Cannabis Market
Columbia Care Inc. (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) (FSE:3LP) launched Seed & Strain brand pre-rolls in all four of its dispensaries in New York.
Mark Cuban Faces Class Action Investor Lawsuit After Promoting Crypto Firm Voyager Digital
Billionaire investor and Dallas Mavericks owner Mark Cuban has been named as a defendant in a class action lawsuit in connection with promoting now-bankrupt crypto brokerage Voyager Digital Ltd (OTC: VYGVQ).
Here’s Why Performance Shipping Stock Is Lower By Over 50% Friday
Performance Shipping Inc (NASDAQ: PSHG) shares are trading lower by 52.33% to $0.29 during Friday's trading session after the company priced its 33 million share offering at $0.45 per share.
What Else?
Aptinyx Shares Plummet As Mid-Stage Fibromyalgia Study Missed Primary Endpoint
Aptinyx Inc. (NASDAQ: APTX) announced results from a Phase 2b clinical study evaluating the effects of NYX-2925 in patients with fibromyalgia.
The Phase 2b clinical study was designed to evaluate the efficacy and safety of NYX-2925 in approximately 300 patients with fibromyalgia.
Aptinyx’s Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study
Aptinyx Inc (NASDAQ: APTX) has announced results from a Phase 2b study evaluating the effects of NYX-2925 in patients with fibromyalgia, characterized by muscular or musculoskeletal pain with stiffness and localized tenderness at specific points.
ARK’s Cathie Wood Dumps More Twitter Stock, Buys $20M in Fate Therapeutics Stock
Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds (ETF) valued at over $20 million based on Thursday’s closing pri
UNITY Biotech Shares More Than Double On Positive Drug Data For Diabetes Associated Vision Loss
UNITY Biotechnology Inc (NASDAQ:UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for…
Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes
Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading.
Forian Q2 Revenue Grows 44% YoY, Here Are The Details
Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022.
Q2 2022 Financial Highlights